Cargando…
Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia
BACKGROUND: The outcome of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) beyond the second-line has not been studied in Saudi Arabia. Therefore, this multicenter retrospective analysis was conducted to evaluate the efficacy of FTD/TPI. MET...
Autores principales: | Alghamdi, Mohammed, Bazarbashi, Shouki, Mahrous, Mervat, Alshaer, Omar, Mostafa Gad, Ahmed, Aseafan, Mohamed, Abdelgelil, Mai, Alshabi, Redhwan Mohammed, Alghanmi, Hosam Ali, Naser, Nasser Ahmed, Al Hariri, Husam, ALHamad, Abdulaziz, Al-Saleh, Khalid, Abdel-Aziz, Nashwa, Elsamany, Sherif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485708/ https://www.ncbi.nlm.nih.gov/pubmed/36147443 http://dx.doi.org/10.1155/2022/3796783 |
Ejemplares similares
-
Biomarkers of Trifluridine-Tipiracil Efficacy
por: Voutsadakis, Ioannis A.
Publicado: (2021) -
Trifluridine/Tipiracil: Old Drug, New Tricks
por: Jeffers, Kate D.
Publicado: (2016) -
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2019) -
Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
por: Chida, Keigo, et al.
Publicado: (2021) -
Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer
por: Kang, Connie, et al.
Publicado: (2019)